Condition
Depressed
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07317895Not Yet RecruitingPrimary
Sensitivity to Ovarian Hormones and Depression in Adolescents
NCT07211984Not ApplicableNot Yet Recruiting
Evaluation of Dalia Solution For Depressed Patient
NCT07179913Phase 4Not Yet RecruitingPrimary
The Improvement of Low-dose Esketamine on Postoperative Depression in Patients Undergoing Bariatric Surgery With Preoperative Depression
NCT02798094CompletedPrimary
Stress Sensitivity and Reward Responsivity in Depression
Showing all 4 trials